PATENT CLAIM ANALYSIS

Application Number: 15761742
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-01
Patent Classification: ["514", "045000"]

Abstract:
The present invention is directed to 4′-substituted nucleoside derivatives of Formula (I) and their use in the inhibition of HIV reverse transcriptase, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS and/or ARC. The present invention also provides processes for the preparation of 4′-substituted nucleoside derivatives of Formula (I) and derivatives thereof.

Claim (Index 7):
A pharmaceutical composition comprising an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.88095
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14669398', '15231365', '16061732', '15616756', '15012445']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7700838375464082
- 35 USC 102 Novelty (BERT): 0.512003621784561
- Combined Prediction Score: 0.7442758159702235
- Mean Citation Score: 279.069942
- Max Citation Score: 316.41708
- Similarity Product: 276.375190398674

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test